NEW YORK (GenomeWeb News) – NanoString Technologies has priced the follow-on public offering of its common stock at $18.50 per share.

The company announced the $55 million offering last week and launched it earlier this week. The bookrunning managers are JP Morgan and Morgan Stanley. The co-managers are Leerink Partners and RW Baird. NanoString has given the underwriters a 30-day option to purchase an additional $8.25 million of its common shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.